OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,654 | -39.1% | 31,737 | 0.0% | 0.00% | – |
| Q2 2023 | $163,763 | -1.5% | 31,737 | +0.6% | 0.00% | – |
| Q1 2023 | $166,205 | +87.5% | 31,538 | 0.0% | 0.00% | – |
| Q4 2022 | $88,622 | -33.1% | 31,538 | -1.2% | 0.00% | – |
| Q3 2022 | $132,431 | -0.1% | 31,911 | -3.3% | 0.00% | – |
| Q2 2022 | $132,612 | -18.7% | 32,988 | +0.1% | 0.00% | – |
| Q1 2022 | $163,132 | -43.7% | 32,956 | -20.9% | 0.00% | – |
| Q4 2021 | $290,000 | -28.9% | 41,653 | +2.2% | 0.00% | – |
| Q3 2021 | $408,000 | -34.2% | 40,772 | -6.8% | 0.00% | -100.0% |
| Q2 2021 | $620,000 | -7.7% | 43,740 | +6.8% | 0.00% | 0.0% |
| Q1 2021 | $672,000 | -20.5% | 40,947 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $845,000 | +221.3% | 40,819 | +18.2% | 0.00% | – |
| Q3 2020 | $263,000 | +0.8% | 34,521 | +9.3% | 0.00% | – |
| Q2 2020 | $261,000 | +83.8% | 31,577 | +10.4% | 0.00% | – |
| Q1 2020 | $142,000 | +31.5% | 28,608 | +4.3% | 0.00% | – |
| Q4 2019 | $108,000 | +22.7% | 27,435 | +0.4% | 0.00% | – |
| Q3 2019 | $88,000 | -26.7% | 27,325 | +0.1% | 0.00% | – |
| Q2 2019 | $120,000 | +14.3% | 27,285 | +2.9% | 0.00% | – |
| Q1 2019 | $105,000 | +123.4% | 26,519 | +123.8% | 0.00% | – |
| Q4 2018 | $47,000 | -74.2% | 11,852 | -55.2% | 0.00% | – |
| Q3 2018 | $182,000 | -2.7% | 26,458 | -4.7% | 0.00% | – |
| Q2 2018 | $187,000 | +19.1% | 27,759 | +15.1% | 0.00% | – |
| Q1 2018 | $157,000 | +528.0% | 24,123 | +328.4% | 0.00% | – |
| Q4 2017 | $25,000 | +212.5% | 5,631 | +317.7% | 0.00% | – |
| Q3 2017 | $8,000 | -95.4% | 1,348 | -92.8% | 0.00% | – |
| Q2 2017 | $174,000 | +24.3% | 18,739 | +24.2% | 0.00% | – |
| Q1 2017 | $140,000 | +28.4% | 15,089 | +15.6% | 0.00% | – |
| Q4 2016 | $109,000 | +172.5% | 13,052 | +122.9% | 0.00% | – |
| Q3 2016 | $40,000 | +900.0% | 5,855 | +672.4% | 0.00% | – |
| Q2 2016 | $4,000 | -96.2% | 758 | -93.2% | 0.00% | – |
| Q1 2016 | $105,000 | +9.4% | 11,183 | +8.9% | 0.00% | – |
| Q4 2015 | $96,000 | -33.3% | 10,270 | 0.0% | 0.00% | – |
| Q3 2015 | $144,000 | -24.2% | 10,270 | +13.5% | 0.00% | – |
| Q2 2015 | $190,000 | -2.6% | 9,049 | +94.5% | 0.00% | – |
| Q1 2015 | $195,000 | +413.2% | 4,652 | +189.5% | 0.00% | – |
| Q4 2014 | $38,000 | – | 1,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |